what bmi for glp-1 & the Role of Semaglutide in Weight Loss Indications for GLP-1/GIP RA Summary

Once weekly subcutaneous injection

Researchers are continuing to investigate the potential benefits of GLP-1 for alcohol addiction

Kitchen & Pantry Essentials: Complete shopping lists with protein and fiber-rich foods to stock your home for success

A rheumatologist explains the 2025 UCLA and ACR research on GLP-1 medications, inflammation, microdosing, and heart risk in RA.

Sacubitril/valsartan has demonstrated consistent benefits not only in HF with reduced ejection fraction (HFrEF) but also in selected patients with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), especially women and those with borderline left ventricular ejection fraction, as shown in the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) and Prospective Comparison of ARNI with ARB Global Outcomes in HF With Preserved Ejection Fraction (PARAGON-HF) trials and supported by Indian ARNI PRESERVED study

Importantly, large-scale randomized trials, meta-analyses, and observational studies suggest that GLP-1RAs do not significantly increase AKI risk and may even confer renal benefits in high-risk populations